<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35119230</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2191-0251</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of pediatric endocrinology &amp; metabolism : JPEM</Title>
          <ISOAbbreviation>J Pediatr Endocrinol Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity.</ArticleTitle>
        <Pagination>
          <StartPage>687</StartPage>
          <EndPage>690</EndPage>
          <MedlinePgn>687-690</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1515/jpem-2021-0674</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">A highly invasive pathological diagnosis is necessary to differentiate central diabetes insipidus (CDI) with a thickened pituitary stalk. Lymphocytic infundibulo-hypophysitis (LIH) due to autoimmune involvement of the pituitary stalk is a differentiating disease, and anti-rabphilin-3A antibody (Rab3A-Ab) positivity was recently reported.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 7-year-old boy was diagnosed with CDI after having polyuria for two months. He showed growth hormone deficiency with reduced growth rate. Brain magnetic resonance imaging (MRI) revealed a thickened pituitary stalk. The placental alkaline phosphatase level of the cerebrospinal fluid, tumor marker for germ cell tumors, was below the level of sensitivity. No skin or bone findings suggestive of Langerhans cell histiocytosis were detected. Eight months after CDI onset, Rab3A-Ab was positive, and MRI showed shrinking of the thickened pituitary stalk, leading to the diagnosis with LIH.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Rab3A-Ab is a useful adjunctive diagnostic tool for childhood-onset LIH.</AbstractText>
          <CopyrightInformation>© 2022 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morota</LastName>
            <ForeName>Kazutaka</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, Nagaoka Red Cross Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tadokoro</LastName>
            <ForeName>Hiroaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, Nagaoka Red Cross Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sawano</LastName>
            <ForeName>Kentaro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Paediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Kenichi</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, Nagaoka Red Cross Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iwata</LastName>
            <ForeName>Naoko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes, Daido Hospital, Nagoya, Aichi, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujisawa</LastName>
            <ForeName>Haruki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sugimura</LastName>
            <ForeName>Yoshihisa</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagasaki</LastName>
            <ForeName>Keisuke</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-5882-661X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, Nagaoka Red Cross Hospital, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Paediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Pediatr Endocrinol Metab</MedlineTA>
        <NlmUniqueID>9508900</NlmUniqueID>
        <ISSNLinking>0334-018X</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C580003">Combined Pituitary Hormone Deficiency</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000069281" MajorTopicYN="Y">Autoimmune Hypophysitis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003919" MajorTopicYN="Y">Diabetes Insipidus</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020790" MajorTopicYN="Y">Diabetes Insipidus, Neurogenic</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007018" MajorTopicYN="N">Hypopituitarism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010902" MajorTopicYN="N">Pituitary Gland</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anti-rabphilin-3A antibody</Keyword>
        <Keyword MajorTopicYN="N">central diabetes insipidus</Keyword>
        <Keyword MajorTopicYN="N">lymphocytic hypophysitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
          <Hour>8</Hour>
          <Minute>43</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35119230</ArticleId>
        <ArticleId IdType="doi">10.1515/jpem-2021-0674</ArticleId>
        <ArticleId IdType="pii">jpem-2021-0674</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Ji, X, Wang, Z, Wang, W, Gao, L, Guo, X, Feng, C, et al.. Clinical characteristics of pediatric patients with sellar and suprasellar lesions who initially present with central diabetes insipidus: a retrospective study of 55 cases from a large pituitary center in China. Front Endocrinol 2020;11:76. https://doi.org/10.3389/fendo.2020.00076.</Citation>
        </Reference>
        <Reference>
          <Citation>Di Iorgi, N, Napoli, F, Allegri, AE, Olivieri, I, Bertelli, E, Gallizia, A, et al.. Diabetes insipidus – diagnosis and management. Horm Res Paediatr 2012;77:69–84. https://doi.org/10.1159/000336333.</Citation>
        </Reference>
        <Reference>
          <Citation>Okamoto, M, Yamaguchi, S, Ishi, Y, Motegi, H, Mori, T, Hashimoto, T, et al.. Diagnostic capability of cerebrospinal fluid-placental alkaline phosphatase value in intracranial germ cell tumor. Oncology 2021;99:23–31. https://doi.org/10.1159/000509395.</Citation>
        </Reference>
        <Reference>
          <Citation>Gellner, V, Kurschel, S, Scarpatetti, M, Mokry, M. Lymphocytic hypophysitis in the pediatric population. Childs Nerv Syst 2008;24:785–92. https://doi.org/10.1007/s00381-007-0577-1.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston, PC, Chew, LS, Hamrahian, AH, Kennedy, L. Lymphocytic infundibulo-neurohypophysitis: a clinical overview. Endocrine 2015;50:531–6. https://doi.org/10.1007/s12020-015-0707-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Iwama, S, Sugimura, Y, Kiyota, A, Kato, T, Enomoto, A, Suzuki, H, et al.. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 2015;100:E946–54. https://doi.org/10.1210/jc.2014-4209.</Citation>
        </Reference>
        <Reference>
          <Citation>Aihara, Y, Watanabe, S, Amano, K, Komatsu, K, Chiba, K, Imanaka, K, et al.. Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors. J Neurosurg 2018;131:687–94. https://doi.org/10.3171/2018.3.JNS172520.</Citation>
        </Reference>
        <Reference>
          <Citation>Vaiani, E, Felizzia, G, Lubieniecki, F, Braier, J, Belgorosky, A. Paediatric Langerhans cell histiocytosis disease: long-term sequelae in the hypothalamic endocrine system. Horm Res Paediatr 2021;94:9–17. https://doi.org/10.1159/000517040.</Citation>
        </Reference>
        <Reference>
          <Citation>Imura, H, Nakao, K, Shimatsu, A, Ogawa, Y, Sando, T, Fujisawa, I, et al.. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 1993;329:683–9. https://doi.org/10.1056/nejm199309023291002.</Citation>
        </Reference>
        <Reference>
          <Citation>Kume, Y, Sakuma, H, Sekine, H, Sumikoshi, M, Sugimura, Y, Hosoya, M. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus. Clin Pediatr Endocrinol 2021;30:65–9. https://doi.org/10.1297/cpe.30.65.</Citation>
        </Reference>
        <Reference>
          <Citation>Joshi, MN, Whitelaw, BC, Carroll, PV. Mechanisms IN endocrinology: hypophysitis: diagnosis and treatment. Eur J Endocrinol 2018;179:151–63. https://doi.org/10.1530/eje-17-0009.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
